Obajed Al-Ali, N.; Csige, D.; Pinczés, L.I.; Farkas, K.; Rebenku, I.; Domján, A.; Panyi, G.; Szekanecz, Z.; Szűcs, G.; Illés, Á.;
et al. Adipokines as Prognostic Biomarkers in Multiple Myeloma: A Case–Control Study. Medicina 2025, 61, 2065.
https://doi.org/10.3390/medicina61112065
AMA Style
Obajed Al-Ali N, Csige D, Pinczés LI, Farkas K, Rebenku I, Domján A, Panyi G, Szekanecz Z, Szűcs G, Illés Á,
et al. Adipokines as Prognostic Biomarkers in Multiple Myeloma: A Case–Control Study. Medicina. 2025; 61(11):2065.
https://doi.org/10.3390/medicina61112065
Chicago/Turabian Style
Obajed Al-Ali, Nóra, Dóra Csige, László Imre Pinczés, Katalin Farkas, István Rebenku, Andrea Domján, György Panyi, Zoltán Szekanecz, Gabriella Szűcs, Árpád Illés,
and et al. 2025. "Adipokines as Prognostic Biomarkers in Multiple Myeloma: A Case–Control Study" Medicina 61, no. 11: 2065.
https://doi.org/10.3390/medicina61112065
APA Style
Obajed Al-Ali, N., Csige, D., Pinczés, L. I., Farkas, K., Rebenku, I., Domján, A., Panyi, G., Szekanecz, Z., Szűcs, G., Illés, Á., & Váróczy, L.
(2025). Adipokines as Prognostic Biomarkers in Multiple Myeloma: A Case–Control Study. Medicina, 61(11), 2065.
https://doi.org/10.3390/medicina61112065